-
1
-
-
72749091725
-
Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer
-
Ge, L.; Baskic, D.; Basse, P.; Vujanovic, L.; Unlu, S.; Yoneyama, T.; Vujanovic, A.; Han, J.; Bankovic, D.; Szczepanski, M. J.; Hunt, J. L.; Herberman, R. B.; Gollin, S. M.; Ferris, R. L.; Whiteside, T. L.; Myers, E. N.; Vujanovic, N. L. Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer Cancer Epidemiol., Biomarkers Prev. 2009, 18, 2913-2922
-
(2009)
Cancer Epidemiol., Biomarkers Prev.
, vol.18
, pp. 2913-2922
-
-
Ge, L.1
Baskic, D.2
Basse, P.3
Vujanovic, L.4
Unlu, S.5
Yoneyama, T.6
Vujanovic, A.7
Han, J.8
Bankovic, D.9
Szczepanski, M.J.10
Hunt, J.L.11
Herberman, R.B.12
Gollin, S.M.13
Ferris, R.L.14
Whiteside, T.L.15
Myers, E.N.16
Vujanovic, N.L.17
-
2
-
-
20244377507
-
Internalization and recycling of ALCAM/CD166 detected by a fully human single chain recombinant antibody
-
Piazza, T.; Cha, E.; Bongarzone, I.; Canevari, S.; Bolognesi, A.; Polito, L.; Bargellesi, A.; Sassi, F.; Ferrini, S.; Fabbi, M. Internalization and recycling of ALCAM/CD166 detected by a fully human single chain recombinant antibody J. Cell Sci. 2005, 118, 1515-1525
-
(2005)
J. Cell Sci.
, vol.118
, pp. 1515-1525
-
-
Piazza, T.1
Cha, E.2
Bongarzone, I.3
Canevari, S.4
Bolognesi, A.5
Polito, L.6
Bargellesi, A.7
Sassi, F.8
Ferrini, S.9
Fabbi, M.10
-
3
-
-
37849020476
-
The ALCAM shedding by the metalloprotease ADAM17/TACE is a tyrosine kinase-inducible process involved in motility of ovarian carcinoma cells
-
Rosso, O.; Piazza, T.; Bongarzone, I.; Rossello, A.; Mezzanzanica, D.; Canevari, S.; Orengo, A. M.; Puppo, A.; Ferrini, S.; Fabbi, M. The ALCAM shedding by the metalloprotease ADAM17/TACE is a tyrosine kinase-inducible process involved in motility of ovarian carcinoma cells Mol. Cancer Res. 2007, 5, 1246-1253
-
(2007)
Mol. Cancer Res.
, vol.5
, pp. 1246-1253
-
-
Rosso, O.1
Piazza, T.2
Bongarzone, I.3
Rossello, A.4
Mezzanzanica, D.5
Canevari, S.6
Orengo, A.M.7
Puppo, A.8
Ferrini, S.9
Fabbi, M.10
-
4
-
-
34247236142
-
Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors
-
Santiago-Josefat, B.; Esselens, C.; Bech-Serra, J. J.; Arribas, J. Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors J. Biol. Chem. 2007, 282, 8325-8331
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 8325-8331
-
-
Santiago-Josefat, B.1
Esselens, C.2
Bech-Serra, J.J.3
Arribas, J.4
-
5
-
-
36048938454
-
TACE: A new target in epidermal growth factor receptor dependent tumors
-
Kenny, P. A. TACE: a new target in epidermal growth factor receptor dependent tumors Differentiation 2007, 75, 800-808
-
(2007)
Differentiation
, vol.75
, pp. 800-808
-
-
Kenny, P.A.1
-
6
-
-
77949791477
-
Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models
-
Nuti, E.; Casalini, F.; Avramova, S. I.; Santamaria, S.; Fabbi, M.; Ferrini, S.; Marinelli, L.; La Pietra, V.; Limongelli, V.; Novellino, E.; Cercignani, G.; Orlandini, E.; Nencetti, S.; Rossello, A. Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models J. Med. Chem. 2010, 53, 2622-2635
-
(2010)
J. Med. Chem.
, vol.53
, pp. 2622-2635
-
-
Nuti, E.1
Casalini, F.2
Avramova, S.I.3
Santamaria, S.4
Fabbi, M.5
Ferrini, S.6
Marinelli, L.7
La Pietra, V.8
Limongelli, V.9
Novellino, E.10
Cercignani, G.11
Orlandini, E.12
Nencetti, S.13
Rossello, A.14
-
7
-
-
84875594480
-
Activated leukocyte cell adhesion molecule soluble form: A potential biomarker of epithelial ovarian cancer is increased in type II tumors
-
Carbotti, G.; Orengo, A. M.; Mezzanzanica, D.; Bagnoli, M.; Brizzolara, A.; Emionite, L.; Puppo, A.; Centurioni, M. G.; Bruzzone, M.; Marroni, P.; Rossello, A.; Canevari, S.; Ferrini, S.; Fabbi, M. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors Int. J. Cancer. 2013, 132, 2597-2605
-
(2013)
Int. J. Cancer.
, vol.132
, pp. 2597-2605
-
-
Carbotti, G.1
Orengo, A.M.2
Mezzanzanica, D.3
Bagnoli, M.4
Brizzolara, A.5
Emionite, L.6
Puppo, A.7
Centurioni, M.G.8
Bruzzone, M.9
Marroni, P.10
Rossello, A.11
Canevari, S.12
Ferrini, S.13
Fabbi, M.14
-
8
-
-
77956763130
-
Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease
-
Becker, D. P.; Barta, T. E.; Bedell, L. J.; Boehm, T. L.; Bond, B. R.; Carroll, J.; Carron, C. P.; DeCrescenzo, G. A.; Easton, A. M.; Freskos, J. N.; Funckes-Shippy, C. L.; Heron, M.; Hockerman, S.; Howard, C. P.; Kiefer, J. R.; Li, M. H.; Mathis, K. J.; McDonald, J. J.; Mehta, P. P.; Munie, G. E.; Sunyer, T.; Swearingen, C. A.; Villamil, C. I.; Welsch, D.; Williams, J. M.; Yu, Y.; Yao, J. Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease J. Med. Chem. 2010, 53, 6653-6680
-
(2010)
J. Med. Chem.
, vol.53
, pp. 6653-6680
-
-
Becker, D.P.1
Barta, T.E.2
Bedell, L.J.3
Boehm, T.L.4
Bond, B.R.5
Carroll, J.6
Carron, C.P.7
Decrescenzo, G.A.8
Easton, A.M.9
Freskos, J.N.10
Funckes-Shippy, C.L.11
Heron, M.12
Hockerman, S.13
Howard, C.P.14
Kiefer, J.R.15
Li, M.H.16
Mathis, K.J.17
McDonald, J.J.18
Mehta, P.P.19
Munie, G.E.20
Sunyer, T.21
Swearingen, C.A.22
Villamil, C.I.23
Welsch, D.24
Williams, J.M.25
Yu, Y.26
Yao, J.27
more..
-
9
-
-
77949834395
-
ADAMs and ADAMTs Selective Synthetic Inhibitors
-
Supuran, C. T. Winum, J.-Y. Wiley Series in Drug Discovery and Development; John Wiley & Sons: Hoboken, NJ
-
Rossello, A.; Nuti, E.; Maresca, A. ADAMs and ADAMTs Selective Synthetic Inhibitors. In Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications; Supuran, C. T.; Winum, J.-Y., Eds.; Wiley Series in Drug Discovery and Development; John Wiley & Sons: Hoboken, NJ, 2009; pp 591-645.
-
(2009)
Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications
, pp. 591-645
-
-
Rossello, A.1
Nuti, E.2
Maresca, A.3
-
11
-
-
52949136266
-
Specific targeting of metzincin family members with small-molecule inhibitors: Progress toward a multifarious challenge
-
Georgiadis, D.; Yiotakis, A. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge Bioorg. Med. Chem. 2008, 16, 8781-8794
-
(2008)
Bioorg. Med. Chem.
, vol.16
, pp. 8781-8794
-
-
Georgiadis, D.1
Yiotakis, A.2
-
13
-
-
0344019404
-
Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme
-
Maskos, K.; Fernandez-Catalan, C.; Huber, R.; Bourenkov, G. P.; Bartunik, H.; Ellestad, G. A.; Reddy, P.; Wolfson, M. F.; Rauch, C. T.; Castner, B. J.; Davis, R.; Clarke, H. R. G.; Petersen, M.; Fitzner, J. N.; Cerretti, D. P.; March, C. J.; Paxton, R. J.; Black, R. A.; Bode, W. Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 3408-3412
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 3408-3412
-
-
Maskos, K.1
Fernandez-Catalan, C.2
Huber, R.3
Bourenkov, G.P.4
Bartunik, H.5
Ellestad, G.A.6
Reddy, P.7
Wolfson, M.F.8
Rauch, C.T.9
Castner, B.J.10
Davis, R.11
Clarke, H.R.G.12
Petersen, M.13
Fitzner, J.N.14
Cerretti, D.P.15
March, C.J.16
Paxton, R.J.17
Black, R.A.18
Bode, W.19
-
15
-
-
84861905720
-
Pharmacological profile of DPC 333, a selective TACE inhibitor
-
Liu, R.; Magolda, R.; Newton, R.; Duan, J.; Vaddi, K.; Madskuie, T.; Qian, M.; Collins, R.; Taylor, T.; Giannaris, J. Pharmacological profile of DPC 333, a selective TACE inhibitor Inflammation Res. 2002, 51, A27
-
(2002)
Inflammation Res.
, vol.51
, pp. 27
-
-
Liu, R.1
Magolda, R.2
Newton, R.3
Duan, J.4
Vaddi, K.5
Madskuie, T.6
Qian, M.7
Collins, R.8
Taylor, T.9
Giannaris, J.10
-
16
-
-
33751057273
-
Identification and characterization of Aprarastat (TMI-005), a potent, dual TACE/MMP inhibitor for the treatment of RA
-
Zhang, Y.; Xu, J.; Udata, C.; McDevitt, J.; Cummons, T.; Sun, L.; Zhu, Y.; Li, G.; Rao, V.; Wang, Q.; Gibbons, J.; Skotnicki, J.; Lin, L.; Levin, J. Identification and characterization of Aprarastat (TMI-005), a potent, dual TACE/MMP inhibitor for the treatment of RA Ann. Rheum. Dis. 2005, 64 (Suppl 3), 462-463
-
(2005)
Ann. Rheum. Dis.
, vol.643
, pp. 462-463
-
-
Zhang, Y.1
Xu, J.2
Udata, C.3
McDevitt, J.4
Cummons, T.5
Sun, L.6
Zhu, Y.7
Li, G.8
Rao, V.9
Wang, Q.10
Gibbons, J.11
Skotnicki, J.12
Lin, L.13
Levin, J.14
-
17
-
-
36349001525
-
-
U.S. Patent Appl. Pub. 0211730.
-
Levin, J.; Li, Z.; Diamantidis, G.; Lovering, F. E.; Wang, W.; Condon, J. S.; Lin, Y.; Skotnicki, J. S.; Park, K. β-Sulfonamide Hydroxamic Acid Inhibitors of TACE/Matrix Metalloproteinase. U.S. Patent Appl. Pub. 0211730, 2006.
-
(2006)
β-Sulfonamide Hydroxamic Acid Inhibitors of TACE/Matrix Metalloproteinase
-
-
Levin, J.1
Li, Z.2
Diamantidis, G.3
Lovering, F.E.4
Wang, W.5
Condon, J.S.6
Lin, Y.7
Skotnicki, J.S.8
Park, K.9
-
18
-
-
58149112487
-
Development of a suitable process for the preparation of a TNF-α converting enzyme inhibitor, WAY-281418
-
Wang, Y.; Papamichelakis, M.; Chew, W.; Sellstedt, J.; Noureldin, R.; Tadayon, S.; Daigneault, S. Development of a suitable process for the preparation of a TNF-α converting enzyme inhibitor, WAY-281418 Org. Process Res. Dev. 2008, 12, 1253-1260
-
(2008)
Org. Process Res. Dev.
, vol.12
, pp. 1253-1260
-
-
Wang, Y.1
Papamichelakis, M.2
Chew, W.3
Sellstedt, J.4
Noureldin, R.5
Tadayon, S.6
Daigneault, S.7
-
19
-
-
84873032924
-
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation
-
Nuti, E.; Santamaria, S.; Casalini, F.; Yamamoto, K.; Marinelli, L.; La Pietra, V.; Novellino, E.; Orlandini, E.; Nencetti, S.; Marini, A. M.; Salerno, S.; Taliani, S.; Da Settimo, F.; Nagase, H.; Rossello, A. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation Eur. J. Med. Chem. 2013, 62, 379-394
-
(2013)
Eur. J. Med. Chem.
, vol.62
, pp. 379-394
-
-
Nuti, E.1
Santamaria, S.2
Casalini, F.3
Yamamoto, K.4
Marinelli, L.5
La Pietra, V.6
Novellino, E.7
Orlandini, E.8
Nencetti, S.9
Marini, A.M.10
Salerno, S.11
Taliani, S.12
Da Settimo, F.13
Nagase, H.14
Rossello, A.15
-
20
-
-
2142828483
-
Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme
-
Neumann, U.; Kubota, H.; Frei, K.; Ganu, V.; Leppert, D. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme Anal. Biochem. 2004, 328, 166-173
-
(2004)
Anal. Biochem.
, vol.328
, pp. 166-173
-
-
Neumann, U.1
Kubota, H.2
Frei, K.3
Ganu, V.4
Leppert, D.5
-
21
-
-
12444254805
-
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates
-
Levin, J. I.; Chen, J. M.; Cheung, K.; Cole, D.; Crago, C.; Santos, E. D.; Du, X.; Khafizova, G.; MacEwan, G.; Niu, C.; Salaski, E. J.; Zask, A.; Cummons, T.; Sung, A.; Xu, J.; Zhang, Y.; Xu, W.; Ayral-Kaloustian, S.; Jin, G.; Cowling, R.; Barone, D.; Mohler, K. M.; Black, R. A.; Skotnicki, J. S. Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates Bioorg. Med. Chem. Lett. 2003, 13, 2799-2803
-
(2003)
Bioorg. Med. Chem. Lett.
, vol.13
, pp. 2799-2803
-
-
Levin, J.I.1
Chen, J.M.2
Cheung, K.3
Cole, D.4
Crago, C.5
Santos, E.D.6
Du, X.7
Khafizova, G.8
MacEwan, G.9
Niu, C.10
Salaski, E.J.11
Zask, A.12
Cummons, T.13
Sung, A.14
Xu, J.15
Zhang, Y.16
Xu, W.17
Ayral-Kaloustian, S.18
Jin, G.19
Cowling, R.20
Barone, D.21
Mohler, K.M.22
Black, R.A.23
Skotnicki, J.S.24
more..
-
22
-
-
73249123318
-
Evolutionary divergence and functions of the ADAM and ADAMTS gene families
-
Brocker, C. N.; Vasiliou, V.; Nebert, D. W. Evolutionary divergence and functions of the ADAM and ADAMTS gene families Hum. Genomics 2009, 4, 43-55
-
(2009)
Hum. Genomics
, vol.4
, pp. 43-55
-
-
Brocker, C.N.1
Vasiliou, V.2
Nebert, D.W.3
-
23
-
-
33745477470
-
Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis
-
Bech-Serra, J. J.; Santiago-Josefat, B.; Esselens, C.; Saftig, P.; Baselga, J.; Arribas, J.; Canals, F. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis Mol. Cell. Biol. 2006, 26, 5086-5095
-
(2006)
Mol. Cell. Biol.
, vol.26
, pp. 5086-5095
-
-
Bech-Serra, J.J.1
Santiago-Josefat, B.2
Esselens, C.3
Saftig, P.4
Baselga, J.5
Arribas, J.6
Canals, F.7
-
24
-
-
69249152227
-
ADAM10 as a therapeutic target for cancer and inflammation
-
Crawford, H. C.; Dempsey, P. J.; Brown, G.; Adam, L.; Moss, M. L. ADAM10 as a therapeutic target for cancer and inflammation Curr. Pharm. Des. 2009, 15, 2288-2299
-
(2009)
Curr. Pharm. Des.
, vol.15
, pp. 2288-2299
-
-
Crawford, H.C.1
Dempsey, P.J.2
Brown, G.3
Adam, L.4
Moss, M.L.5
-
25
-
-
39449083877
-
ADAM10 as a target for anticancer therapy
-
Moss, M. L.; Stoeck, A.; Yan, W.; Dempsey, P. J. ADAM10 as a target for anticancer therapy Curr. Pharm. Biotechnol. 2008, 9, 2-8
-
(2008)
Curr. Pharm. Biotechnol.
, vol.9
, pp. 2-8
-
-
Moss, M.L.1
Stoeck, A.2
Yan, W.3
Dempsey, P.J.4
-
26
-
-
84886549647
-
-
version 5.5; Schrödinger, LLC: New York.
-
Glide, version 5.5; Schrödinger, LLC: New York, 2009.
-
(2009)
Glide
-
-
-
27
-
-
0028007891
-
1.56 Å structure of mature truncated human fibroblast collagenase
-
Spurlino, J. C.; Smallwood, A. M.; Carlton, D. D.; Banks, T. M.; Vavra, K. J.; Johnson, J. S.; Cook, E. R.; Falvo, J.; Wahl, R. C.; Pulvino, T. A.; Wendoloski, J. J.; Smith, D. L. 1.56 Å structure of mature truncated human fibroblast collagenase Proteins 1994, 19, 98-109
-
(1994)
Proteins
, vol.19
, pp. 98-109
-
-
Spurlino, J.C.1
Smallwood, A.M.2
Carlton, D.D.3
Banks, T.M.4
Vavra, K.J.5
Johnson, J.S.6
Cook, E.R.7
Falvo, J.8
Wahl, R.C.9
Pulvino, T.A.10
Wendoloski, J.J.11
Smith, D.L.12
-
28
-
-
77954827231
-
The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function
-
Grossman, M.; Tworowski, D.; Dym, O.; Lee, M. H.; Levy, Y.; Murphy, G.; Sagi, I. The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function Biochemistry 2010, 49, 6184-6192
-
(2010)
Biochemistry
, vol.49
, pp. 6184-6192
-
-
Grossman, M.1
Tworowski, D.2
Dym, O.3
Lee, M.H.4
Levy, Y.5
Murphy, G.6
Sagi, I.7
-
29
-
-
80052993945
-
Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor
-
Hashimoto, H.; Takeuchi, T.; Komatsu, K.; Miyazaki, K.; Sato, M.; Higashi, S. Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor J. Biol. Chem. 2011, 286, 33236-33243
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 33236-33243
-
-
Hashimoto, H.1
Takeuchi, T.2
Komatsu, K.3
Miyazaki, K.4
Sato, M.5
Higashi, S.6
-
30
-
-
84877011605
-
-
Manuscript to be published.
-
Nuti, E.; Antoni, C.; Vera, L.; Devel, L.; Beau, F.; Da Pozzo, E.; Costa, B.; Giacomelli, C.; Orlandini, E.; Nencetti, S.; Rosalia, L.; Dive, V.; Stura, E. A.; Martini, C.; Rossello, A. Powerful twin carboxylic inhibitors for MMP homodimeriation. Manuscript to be published.
-
Powerful Twin Carboxylic Inhibitors for MMP Homodimeriation
-
-
Nuti, E.1
Antoni, C.2
Vera, L.3
Devel, L.4
Beau, F.5
Da Pozzo, E.6
Costa, B.7
Giacomelli, C.8
Orlandini, E.9
Nencetti, S.10
Rosalia, L.11
Dive, V.12
Stura, E.A.13
Martini, C.14
Rossello, A.15
-
31
-
-
84886541872
-
-
version 4.7.1; Molecular Devices: Sunnyvale, CA.
-
SoftMax Pro, version 4.7.1; Molecular Devices: Sunnyvale, CA.
-
SoftMax Pro
-
-
-
32
-
-
84886485407
-
-
version 4; Erithecus Software: West Sussex, U.K.
-
GraFit, version 4; Erithecus Software: West Sussex, U.K.
-
GraFit
-
-
-
33
-
-
84886530345
-
-
version 9.1; Schrödinger, LLC: New York.
-
Maestro, version 9.1; Schrödinger, LLC: New York, 2009.
-
(2009)
Maestro
-
-
-
34
-
-
4444221565
-
UCSF chimera: A visualization system for exploratory research and analysis
-
Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. UCSF chimera: a visualization system for exploratory research and analysis J. Comput. Chem. 2004, 25, 1605-1612
-
(2004)
J. Comput. Chem.
, vol.25
, pp. 1605-1612
-
-
Pettersen, E.F.1
Goddard, T.D.2
Huang, C.C.3
Couch, G.S.4
Greenblatt, D.M.5
Meng, E.C.6
Ferrin, T.E.7
-
35
-
-
12144289984
-
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
-
Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy J. Med. Chem. 2004, 47, 1739-1749
-
(2004)
J. Med. Chem.
, vol.47
, pp. 1739-1749
-
-
Friesner, R.A.1
Banks, J.L.2
Murphy, R.B.3
Halgren, T.A.4
Klicic, J.J.5
Mainz, D.T.6
Repasky, M.P.7
Knoll, E.H.8
Shelley, M.9
Perry, J.K.10
Shaw, D.E.11
Francis, P.12
Shenkin, P.S.13
-
36
-
-
33750124980
-
Extra precision Glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
-
Friesner, R. A.; Murphy, R. B.; Repasky, M. P.; Frye, L. L.; Greenwood, J. R.; Halgren, T. A.; Sanschagrin, P. C.; Mainz, D. T. Extra precision Glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes J. Med. Chem. 2006, 49, 6177-6196
-
(2006)
J. Med. Chem.
, vol.49
, pp. 6177
-
-
Friesner, R.A.1
Murphy, R.B.2
Repasky, M.P.3
Frye, L.L.4
Greenwood, J.R.5
Halgren, T.A.6
Sanschagrin, P.C.7
Mainz, D.T.8
|